Scarica l'app Stockscreener
16.76
2.50%
-0.43
Dopo l'orario di chiusura:
17.00
0.24
+1.43%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$17.19
Aprire:
$17.29
Volume 24 ore:
503.39K
Relative Volume:
0.92
Capitalizzazione di mercato:
$455.11M
Reddito:
$157.75M
Utile/perdita netta:
$-29.73M
Rapporto P/E:
-14.45
EPS:
-1.16
Flusso di cassa netto:
$-21.00M
1 W Prestazione:
-3.12%
1M Prestazione:
+37.38%
6M Prestazione:
+8.20%
1 anno Prestazione:
-12.07%
Intervallo 1D:
$16.17
$17.43
Intervallo di 1 settimana:
$16.17
$17.70
Portata 52W:
$8.04
$25.88
Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile
Nome
Arcturus Therapeutics Holdings Inc
Settore
Industria
Telefono
(858) 900-2660
Indirizzo
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Confronta ARCT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARCT
Arcturus Therapeutics Holdings Inc
|
16.76 | 453.48M | 157.75M | -29.73M | -21.00M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-28 | Iniziato | Scotiabank | Sector Outperform |
| 2025-01-28 | Iniziato | BTIG Research | Buy |
| 2024-08-12 | Iniziato | Leerink Partners | Outperform |
| 2023-12-13 | Iniziato | Canaccord Genuity | Buy |
| 2023-07-24 | Iniziato | William Blair | Outperform |
| 2023-05-11 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-11-14 | Ripresa | Wells Fargo | Overweight |
| 2022-11-10 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2022-11-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-11-02 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-08-10 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2022-07-19 | Ripresa | Cantor Fitzgerald | Overweight |
| 2022-05-11 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
| 2022-04-21 | Downgrade | Citigroup | Buy → Neutral |
| 2022-01-31 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2021-08-12 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2021-08-11 | Downgrade | Goldman | Neutral → Sell |
| 2021-08-10 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2021-07-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-06-25 | Ripresa | Goldman | Neutral |
| 2021-06-21 | Downgrade | Barclays | Equal Weight → Underweight |
| 2021-06-04 | Ripresa | Robert W. Baird | Neutral |
| 2021-02-17 | Downgrade | B. Riley Securities | Neutral → Sell |
| 2021-01-19 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-01-15 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-01-07 | Iniziato | Wells Fargo | Overweight |
| 2020-12-29 | Downgrade | Barclays | Overweight → Equal Weight |
| 2020-12-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-12-29 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-12-29 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-12-23 | Downgrade | ROTH Capital | Buy → Sell |
| 2020-12-08 | Reiterato | B. Riley Securities | Buy |
| 2020-12-07 | Reiterato | B. Riley Securities | Buy |
| 2020-10-26 | Iniziato | Barclays | Overweight |
| 2020-10-06 | Iniziato | Citigroup | Buy |
| 2020-08-26 | Iniziato | Piper Sandler | Overweight |
| 2020-07-30 | Ripresa | ROTH Capital | Buy |
| 2020-07-16 | Iniziato | Raymond James | Outperform |
| 2020-07-13 | Iniziato | B. Riley FBR | Buy |
| 2020-06-09 | Downgrade | WBB Securities | Buy → Hold |
| 2020-02-11 | Iniziato | Robert W. Baird | Outperform |
| 2020-02-07 | Iniziato | Guggenheim | Buy |
| 2020-02-06 | Iniziato | Guggenheim | Buy |
| 2019-04-05 | Iniziato | H.C. Wainwright | Buy |
| 2018-09-20 | Aggiornamento | WBB Securities | Buy → Strong Buy |
| 2018-01-22 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Arcturus Therapeutics Holdings Inc Borsa (ARCT) Ultime notizie
Visual trend scoring systems applied to Arcturus Therapeutics Holdings Inc.2025 Year in Review & Free Expert Verified Stock Movement Alerts - Newser
How institutional ownership impacts Arcturus Therapeutics Holdings Inc. stockRecession Risk & Low Risk Entry Point Tips - Newser
Is Arcturus Therapeutics Holdings Inc. vulnerable to short sellersEarnings Risk Summary & Stepwise Trade Signal Guides - khodrobank.com
Is a relief rally coming for Arcturus Therapeutics Holdings Inc. holders2025 Volatility Report & Daily Profit Maximizing Tips - Newser
Top chart patterns to watch in Arcturus Therapeutics Holdings Inc.July 2025 Update & Free Long-Term Investment Growth Plans - Newser
When is the best time to exit Arcturus Therapeutics Holdings Inc.Forecast Cut & AI Based Buy and Sell Signals - Newser
What Fibonacci levels say about Arcturus Therapeutics Holdings Inc. reboundJuly 2025 Recap & Expert Curated Trade Ideas - Newser
What’s the beta of Arcturus Therapeutics Holdings Inc. stock2025 Year in Review & Technical Pattern Based Signals - khodrobank.com
Signal strength of Arcturus Therapeutics Holdings Inc. stock in tech scannersJuly 2025 Spike Watch & Capital Protection Trading Alerts - Newser
Volume spikes in Arcturus Therapeutics Holdings Inc. stock – what they meanJuly 2025 PreEarnings & Risk Controlled Daily Plans - Newser
How to integrate Arcturus Therapeutics Holdings Inc. into portfolio analysis toolsEarnings Recap Summary & Risk Managed Investment Entry Signals - Newser
How sentiment analysis helps forecast Arcturus Therapeutics Holdings Inc.Portfolio Update Report & Growth Oriented Trade Recommendations - Newser
Is Arcturus Therapeutics Holdings Inc. affected by consumer sentimentJuly 2025 Decliners & Accurate Entry and Exit Point Alerts - khodrobank.com
How to build a dashboard for Arcturus Therapeutics Holdings Inc. stockEarnings Miss & Long-Term Growth Stock Strategies - Newser
Can Arcturus Therapeutics Holdings Inc. Escape Recent Bear Channel2025 Momentum Check & Pattern Based Trade Signal System - beatles.ru
Intraday pattern recognizer results for Arcturus Therapeutics Holdings Inc.2025 Breakouts & Breakdowns & Safe Entry Zone Tips - Newser
Is Arcturus Therapeutics Holdings Inc. stock undervalued right nowWeekly Gains Report & Low Drawdown Investment Strategies - khodrobank.com
How to track smart money flows in Arcturus Therapeutics Holdings Inc.2025 Technical Overview & Weekly Watchlist for Hot Stocks - Newser
Real time alert setup for Arcturus Therapeutics Holdings Inc. performance2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q2 2025 Earnings Call Transcript - MSN
US High Growth Tech Stocks To Watch Now - simplywall.st
Should You Buy Arcturus Therapeutics (ARCT) After Golden Cross? - Zacks Investment Research
Using data tools to time your Arcturus Therapeutics Holdings Inc. exit2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser
Relative strength of Arcturus Therapeutics Holdings Inc. in sector analysis2025 Risk Factors & Smart Money Movement Alerts - Newser
Automated trading signals detected on Arcturus Therapeutics Holdings Inc.July 2025 Recap & Capital Efficient Trade Techniques - Newser
Arcturus Therapeutics Holdings Inc. recovery potential after sell offForecast Cut & AI Based Buy and Sell Signals - Newser
Can you recover from losses in Arcturus Therapeutics Holdings Inc.Watch List & Target Return Focused Picks - Newser
Will Arcturus Therapeutics Holdings Inc. outperform the market2025 Key Lessons & Daily Technical Forecast Reports - Newser
Is Arcturus Therapeutics Holdings Inc. forming a reversal pattern2025 Pullback Review & Fast Entry High Yield Stock Tips - Newser
How to escape a deep drawdown in Arcturus Therapeutics Holdings Inc.2025 Trading Volume Trends & AI Driven Stock Price Forecasts - Newser
Is Arcturus Therapeutics Holdings Inc. stock entering bullish territoryJuly 2025 Fed Impact & Consistent Profit Focused Trading Strategies - Newser
How Arcturus Therapeutics Holdings Inc. stock performs during market volatilityJuly 2025 Earnings & Long-Term Safe Return Strategies - Newser
Arcturus Therapeutics’ Strategic Shift: Focusing on mRNA Therapeutics to Extend Cash Runway and Drive Long-Term Value - AInvest
Strategies to average down on Arcturus Therapeutics Holdings Inc.Weekly Market Outlook & Safe Entry Trade Signal Reports - Newser
Published on: 2025-08-30 22:19:33 - Newser
Arcturus Therapeutics Holdings Inc Azioni (ARCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):